GROUP ONE TRADING, L.P. - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 18 filers reported holding VASCULAR BIOGENICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q3 2023$23,712
-19.0%
97,182
-23.7%
0.00%
Q2 2023$29,277
+2.4%
127,293
-25.3%
0.00%
Q1 2023$28,592
-11.7%
170,493
-36.8%
0.00%
Q4 2022$32,397
-29.6%
269,972
-7.9%
0.00%
Q3 2022$46,000
-84.4%
293,118
+59.9%
0.00%
Q2 2022$295,000
+1635.3%
183,370
+1739.8%
0.00%
Q1 2022$17,000
-65.3%
9,967
-59.6%
0.00%
Q4 2021$49,000
-41.0%
24,678
-39.0%
0.00%
Q3 2021$83,000
-15.3%
40,429
-1.7%
0.00%
Q2 2021$98,000
+512.5%
41,146
+418.9%
0.00%
Q1 2021$16,000
+128.6%
7,930
+41.6%
0.00%
Q4 2019$7,000
-68.2%
5,600
-61.0%
0.00%
Q1 2019$22,000
+46.7%
14,367
-8.9%
0.00%
Q4 2018$15,0000.0%15,767
+66.4%
0.00%
Q3 2018$15,000
-76.6%
9,476
-67.6%
0.00%
-100.0%
Q2 2018$64,000
-44.3%
29,220
-41.5%
0.00%0.0%
Q1 2018$115,000
-60.1%
49,933
+22.9%
0.00%
-50.0%
Q4 2017$288,000
+1340.0%
40,630
+997.8%
0.00%
Q1 2017$20,000
-39.4%
3,701
-46.3%
0.00%
Q4 2016$33,000
+1550.0%
6,889
+1671.0%
0.00%
Q3 2016$2,000
-94.7%
389
-95.3%
0.00%
Q2 2016$38,0008,3000.00%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,593,286$4,382,0001.02%
Telemetry Investments, L.L.C. 75,000$127,0000.20%
Ikarian Capital, LLC 830,747$1,404,0000.18%
DLD Asset Management, LP 550,000$930,0000.06%
Phoenix Holdings Ltd. 1,020,000$1,724,0000.03%
Spectrum Planning & Advisory Services Inc. 16,000$27,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$135,0000.00%
HBK Sorce Advisory LLC 22,325$38,0000.00%
B. Riley Wealth Management, Inc. 12,000$20,0000.00%
TWO SIGMA SECURITIES, LLC 12,155$21,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders